申请人:Mitsubishi Pharma Corporation
公开号:EP1842556A1
公开(公告)日:2007-10-10
A prophylactic and/or therapeutic drug for AD/HD, containing teniloxazine or an optical isomer thereof, or a pharmaceutically acceptable salt thereof, or a hydrate thereof, as the active ingredient.
一种预防和/或治疗注意力缺陷/多动症的药物,其活性成分含有替尼洛嗪或其光学异构体,或其药学上可接受的盐,或其水合物。